Assessment of tumor treatment response using active contrast encoding (ACE)-MRI: Comparison with conventional DCE-MRI
Autor: | Jin Zhang, Sungheon Kim, Kerryanne V. Winters, Mehran Baboli, Karl Kiser |
---|---|
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
Gadolinium DTPA
Muscle Physiology Muscle Functions Physiology Cancer Treatment Contrast Media 030218 nuclear medicine & medical imaging Diagnostic Radiology Scan time Correlation Mice 0302 clinical medicine Medicine and Health Sciences skin and connective tissue diseases Mice Inbred BALB C Multidisciplinary medicine.diagnostic_test Chemistry Pharmaceutics Radiology and Imaging Limits of agreement Animal Models Magnetic Resonance Imaging Bevacizumab Data Acquisition Oncology Experimental Organism Systems Medicine Fluorouracil Anatomy Research Article Treatment response Computer and Information Sciences Imaging Techniques Science Muscle Tissue Antineoplastic Agents Mouse Models Research and Analysis Methods Sensitivity and Specificity 03 medical and health sciences Model Organisms Drug Therapy Diagnostic Medicine Cell Line Tumor medicine Animals Mouse tumor business.industry Tumor therapy Biology and Life Sciences Magnetic resonance imaging Neoplasms Experimental Mice Inbred C57BL Biological Tissue Tumor progression Animal Studies Nuclear medicine business Drug Delivery 030217 neurology & neurosurgery |
Zdroj: | PLoS ONE, Vol 15, Iss 6, p e0234520 (2020) PLoS ONE |
ISSN: | 1932-6203 |
Popis: | PurposeTo investigate the validity of contrast kinetic parameter estimates from Active Contrast Encoding (ACE)-MRI against those from conventional Dynamic Contrast-Enhanced (DCE)-MRI for evaluation of tumor treatment response in mouse tumor models.MethodsThe ACE-MRI method that incorporates measurement of T1 and B1 into the enhancement curve washout region, was implemented on a 7T MRI scanner to measure tracer kinetic model parameters of 4T1 and GL261 tumors with treatment using bevacizumab and 5FU. A portion of the same ACE-MRI data was used for conventional DCE-MRI data analysis with a separately measured pre-contrast T1 map. Tracer kinetic model parameters, such as Ktrans (permeability area surface product) and ve (extracellular space volume fraction), estimated from ACE-MRI were compared with those from DCE-MRI, in terms of correlation and Bland-Altman analyses.ResultsA three-fold increase of the median Ktrans by treatment was observed in the flank 4T1 tumors by both ACE-MRI and DCE-MRI. In contrast, the brain tumors did not show a significant change by the treatment in either ACE-MRI or DCE-MRI. Ktrans and ve values of the tumors from ACE-MRI were strongly correlated with those from DCE-MRI methods with correlation coefficients of 0.92 and 0.78, respectively, for the median values of 17 tumors. The Bland-Altman plot analysis showed a mean difference of -0.01 min-1 for Ktrans with the 95% limits of agreement of -0.12 min-1 to 0.09 min-1, and -0.05 with -0.37 to 0.26 for ve.ConclusionThe tracer kinetic model parameters estimated from ACE-MRI and their changes by treatment closely matched those of DCE-MRI, which suggests that ACE-MRI can be used in place of conventional DCE-MRI for tumor progression monitoring and treatment response evaluation with a reduced scan time. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |